Keros Therapeutics Inc (KROS)

Equity Ratio

91.21%

TTM · Retrieved:

KROS logo

KROS Equity Ratio

Current (TTM)91.21%
KROS Equity Ratio (46.54% → 91.21%)
High-resolution chart · PNG

KROS equity ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Equity Ratio — Annual fiscal periods
Period endingEquity Ratio
89.6785%
92.8018%
89.7812%
90.4303%
95.2686%
97.1341%
4.5185%
46.5417%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.